Orion Transforms its Clinical Trials with Medidata
Summary
The company can now optimize operational execution, reduce the number of clinical systems, decrease data entry and maintenance burdens, and increase the speed of its trials. “When selecting our platform we needed confidence that it could support big changes, both in our business and the wider industry,” said Olavi Kikku, director R&D data science & analytics at Orion Corporation. “The company understands the power of leveraging advanced solutions on a unified platform to reduce risk, accelerate time to market and improve outcomes. Powered by artificial intelligence and delivered by top-ranked industry experts, Medidata helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk and optimize outcomes. Medidata and its companies, Acorn AI and SHYFT, serve 1,300 customers and partners worldwide and empower more than 150,000 certified users every day to create hope for millions of patients.